Clinical trial
Evaluation of the Efficacy of Donepezil in the Treatment of Oxaliplatin-induced Peripheral Neuropathy: Proof of Concept Study
NCT05254639 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Donepezil in the Treatment of Oxaliplatin-induced Peripheral Neuropathy: Proof of Concept Study
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 2, 2022
- Completion date
- January 24, 2024
- Enrollment
- 77 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.
digestive oncology, supportive care